000048430 000__ 01663cam\a22004335i\4500
000048430 001__ 48430
000048430 003__ SzGeWIPO
000048430 005__ 20230817181954.0
000048430 006__ m\\\\eo\\d\\\\\\\\
000048430 007__ cr bn |||m|||a
000048430 008__ 230714s2023    nyu|||||o|||||000|0 eng|d
000048430 035__ $$a(OCoLC)1393694235
000048430 040__ $$aSzGeWIPO$$beng$$erda$$cSzGeWIPO
000048430 041__ $$aeng
000048430 24500 $$aClinical trial data transparency in the EU: is the new Clinical Trials Regulation a game-changer?
000048430 264_1 $$a[New York, NY] :$$bThomson Reuters,$$c2023
000048430 300__ $$a1 online resource
000048430 336__ $$atext$$2rdacontent
000048430 337__ $$acomputer$$2rdamedia
000048430 338__ $$aonline resource$$bcr$$2rdacarrier
000048430 4901_ $$aInternational Review of Intellectual Property Law & Competition Law ;$$vVolume 54, Issue 5
000048430 542__ $$fhttps://1.next.westlaw.com/Copyright
000048430 588__ $$aCrossref
000048430 590__ $$aPublished online: 2023
000048430 650_0 $$aIntellectual property.$$zEuropean Union.
000048430 650_0 $$aData protection.
000048430 650_0 $$aHealth.
000048430 650_0 $$aPharmaceuticals.
000048430 650_0 $$aClinical trials.
000048430 650_0 $$aMedical records$$xAccess control.
000048430 650_0 $$aIntellectual property.
000048430 7001_ $$aZemla-Pacud, Zaneta,$$eauthor.
000048430 7001_ $$aLenarczyk, Gabriela,$$eauthor.
000048430 7731_ $$tInternational Review of Intellectual Property Law & Competition Law
000048430 7731_ $$wIIC
000048430 830_0 $$aInternational Review of Intellectual Property Law & Competition Law ;$$vVolume 54, Issue 5.
000048430 85641 $$uhttps://www.westlaw.com/Document/IB9B13F90FF4911EDA9EFDF2DE8193E38/View/FullText.html?transitionType=Default&contextData=(sc.Default)&VR=3.0&RS=cblt1.0&sp=wlnintell-000$$yonline version
000048430 904__ $$aArticle
000048430 980__ $$aIIC